Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A549 | IC50 | > 10 μM | Cytotoxicity against human A549 cells after 48 hrs by MTT assay | [PMID: 25710081] |
| A549 | IC50 | 3.1 μM | Cytotoxicity against human A549 cells after 4 days by MTT assay | [PMID: 24359303] |
| A549 | GI50 | 42 μM | Antiproliferative activity against human A549 cells after 48 hrs by sulforhodamine B assay | [PMID: 25752525] |
| B16-4A5 | IC50 | 17 μM | Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells after 72 hrs | [PMID: 20189399] |
| Bel-7402 | IC50 | 3.7 μM | Cytotoxicity against human Bel7402 cells after 4 days by MTT assay | [PMID: 24359303] |
| BMDM | IC50 | 15 μM | Inhibition of M-CSF/RANKL-induced osteoclast differentiation in C57BL/6 mouse bone marrow macrophage assessed as reduction in multinucleated TRAP+ cells incubated for 6 days with fresh media replacement on day 3 and measured on day 6 by TRAP staining-base | [PMID: 31257875] |
| BV-2 | IC50 | > 100 μM | Antineuroinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced NO production after 24 hrs in presence of LPS by Griess reaction based assay | [PMID: 28911817] |
| DLD-1 | IC50 | 70 μM | Cytotoxicity against human DLD1 cells after 96 hrs by MTT assay | [PMID: 15387639] |
| HBL-100 | GI50 | > 100 μM | Antiproliferative activity against human HBL100 cells after 48 hrs by sulforhodamine B assay | [PMID: 25752525] |
| HeLa | GI50 | 49 μM | Antiproliferative activity against human HeLa cells after 48 hrs by sulforhodamine B assay | [PMID: 25752525] |
| HepG2 2.2.15 | EC50 | 2.46 μg/mL | Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV e antigen secretion by ELISA | [PMID: 24549242] |
| HepG2 2.2.15 | EC50 | 3.94 μg/mL | Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion by ELISA | [PMID: 24549242] |
| HepG2 2.2.15 | IC50 | 4.17 μg/mL | Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production by quantitative RT-PCR analysis | [PMID: 24549242] |
| K562 | IC50 | > 10 μM | Cytotoxicity against human K562 cells after 48 hrs by MTT assay | [PMID: 25710081] |
| KB | IC50 | > 10 μM | Cytotoxicity against human KB cells after 4 days by MTT assay | [PMID: 24359303] |
| N9 | IC50 | > 100 μM | Antineuroinflammatory activity in mouse N9 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess assay | [PMID: 28073678] |
| SW1573 | GI50 | 54 μM | Antiproliferative activity against human SW1573 cells after 48 hrs by sulforhodamine B assay | [PMID: 25752525] |
| T47D | GI50 | > 100 μM | Antiproliferative activity against human T47D cells after 48 hrs by sulforhodamine B assay | [PMID: 25752525] |
| WiDr | GI50 | > 100 μM | Antiproliferative activity against human WiDr cells after 48 hrs by sulforhodamine B assay | [PMID: 25752525] |
19 records · Scroll to view more